Patient Organisation Statement on NHS England Commercial Framework Consultation, September 2024
top of page
Patient Organisation Statement on NHS England Commercial Framework Consultation
NICE Including Technology Appraisal Recommendations in Guideline Topic Areas consultation – Cancer52’s response
Cancer52 submitted a response on the National Institute for Health and Care Excellence (NICE) consultation on proposed changes to...
NICE consultation on Integrated Topic Prioritisation and Strategic Principles – Cancer52’s response
In April 2024, Cancer52 submitted a response on National Institute for Health and Care Excellence (NICE) consultation on its new approach...
Consultation on Working Alongside People and Communities at NICE – Cancer52’s response
National Institute for Health and Care Excellence (NICE) consulted on a new Working alongside people and communities at NICE: a...
Role of Incentive Schemes in General Practice consultation – Cancer52’s response
The Department of Health and Social Care (DHSC) held a consultation on the role of incentive schemes in general practice in...
Department of Health and Social Care Statistical outputs consultation – Cancer52’s response
The Department of Health and Social Care (DHSC) held a consultation on Health and social care statistical outputs published by DHSC...
ABPI's Code of Practice consultation – Cancer52’s response
Cancer52 responded to the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice consultation that ran in early...
Cancer52 response to the Major Conditions Strategy Strategic Framework
September 2023 The Department for Health and Social Care (DHSC) published an interim case for change and strategic framework as part of...
Health and Social Care Committee report on Cancer services
Cancer52 welcomes the Health and Social Care Select Committee’s report on Cancer Services, published today (Tuesday 5 April 2022). Read...
10-Year Cancer Plan: Cancer52 response to the Call for Evidence
Cancer52, which has more than 100 cancer charity members working in rare and less common cancers, has submitted a response to the...
bottom of page